<DOC>
	<DOCNO>NCT01812902</DOCNO>
	<brief_summary>Prostate cancer currently second common cause cancer death men Western country . Lymphadenectomy gold standard procedure stag pelvic lymph node classically indicated intermediate high risk prostate cancer patient hold time prostatectomy . A traditionally pelvic lymphadenectomy cover obturator chain bilaterally . Recently , study demonstrate existence lymph node involvement outside traditional boundary classical lymphadenectomy , recommend therefore extended dissection ; also include external / internal / common iliac chain presacral . Thus lymphadenectomy , accord author , would also therapeutic role , besides help good stag . Although retrospective study report association lymphadenectomy tumor progression , exact impact extend lymphadenectomy oncological outcome patient prostate cancer clearly establish , mainly lack prospective randomize study subject . The study objective compare oncologic result extend lymphadenectomy versus limit order elucidate role extend dissection lymph node stag result treatment term increase tumor cure . The investigator also intend identify patient may benefit oncologically extended procedure . To , investigator evaluate prospectively patient diagnosed prostate cancer intermediate high risk indicate lymphadenectomy radical prostatectomy . These patient randomize extended versus limit lymphadenectomy investigator compare lymph node metastasis pattern spread prostate cancer , well biochemical relapse-free survival , freedom progression metastasis cancer-specific survival .</brief_summary>
	<brief_title>Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy Intermediate High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Prostate Cancer patient intermediate high risk indication radical prostatectomy LND Absence bone metastasis organ image test ( MRI scintigraphy ) Absence hormone treatment Absence radiotherapy Signing inform consent Availability adequacy lymph node tissue sample perform immunohistochemical Life expectancy le 10 year Absence clinical condition procedure Laparoscopic perineal surgery Presence bone visceral metastasis Neoadjuvant treatment Another malignant neoplasia Prior abdominal pelvic surgery</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Prostate specific antigen</keyword>
	<keyword>lymphadenectomy</keyword>
	<keyword>Limited lymphadenectomy</keyword>
	<keyword>Extended lymphadenectomy</keyword>
	<keyword>Immunohistochemistry</keyword>
</DOC>